Petesicatib Completed Phase 1 Trials for Gluten-Sensitive Enteropathy Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 1 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT02679014 | A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease |